Liv Tone Eliassen

Title: Liv Tone Eliassen: Innovator in Tumor Growth Inhibition

Introduction

Liv Tone Eliassen is a notable inventor based in Kvaloysletta, Norway. She has made significant contributions to the field of medical science, particularly in the development of innovative peptides for tumor growth inhibition. With a total of 2 patents, her work is paving the way for new therapeutic approaches in oncology.

Latest Patents

Eliassen's latest patents focus on the inhibition of tumor growth. The inventions provide a cytotoxic 7 to 25 mer peptide that contains three or more cationic residues. These peptides also include one or more non-genetic bulky and lipophilic amino acids, along with esters, amides, salts, and cyclic derivatives. The patents detail methods for preparing these peptides, pharmaceutical compositions that contain them, and their applications as medicaments, particularly as antibacterials or antitumoral agents. A preferred aspect of her invention is the use of these peptides in methods aimed at inducing adaptive immunity against tumor growth or establishment in a subject.

Career Highlights

Liv Tone Eliassen is currently associated with Lytix Biopharma AS, where she continues her research and development efforts. Her work is instrumental in advancing the understanding of how specific peptides can be utilized in cancer treatment.

Collaborations

Eliassen collaborates with esteemed colleagues such as Gerd Berge and Baldur Sveinbjørnsson, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Liv Tone Eliassen is a pioneering inventor whose work in tumor growth inhibition is making a significant impact in the medical field. Her innovative approaches and collaborations are essential in the ongoing fight against cancer.